Direct answer: Corvian Advisory provides sell-side, buy-side, financial due diligence and business valuation for China-related M&A. We advise on SAFE foreign exchange approvals, MOFCOM anti-monopoly filings, VIE structure assessment and UAE–China cross-border structuring. Minimum deal size: CNY 10M (~AED 5M / USD 1.4M). The UAE is an increasingly important hub for Chinese outbound capital and a structuring gateway for GCC investors accessing Chinese assets.
Six specialist services built for the regulatory and commercial complexity of China-related M&A, from SAFE-compliant cross-border structuring to CAS/IFRS financial due diligence and VIE assessment.
{{ svc.body }}
China M&A demands a rare combination: deep financial due diligence skills, multi-regulator navigation (SAFE, MOFCOM, CSRC, NDRC) and cross-border structuring expertise. Corvian delivers all three, with UAE market credibility that matters to Chinese counterparties.
{{ w.body }}
China's domestic M&A market remains large but highly regulated. Inbound foreign investment is subject to the Negative List, sectors where foreign ownership is restricted or prohibited. Mid-market transactions in manufacturing, clean energy, consumer goods and technology have seen sustained activity.
Chinese outbound M&A has rebounded post-2022, with UAE increasingly positioned as the primary non-Western M&A corridor. Chinese companies use UAE holding structures to access GCC markets, manage USD settlement and reduce regulatory friction for third-country investments.
BRI-related investment continues to flow through UAE infrastructure, JAFZA is a major logistics hub for BRI corridor activity. UAE–China bilateral trade exceeds AED 200B annually. Abu Dhabi sovereign entities (ADIA, Mubadala) have significant China allocations.
Standard PRC CIT is 25%. HNTE status reduces CIT to 15%, a key valuation input validated in FDD. Dividend WHT: 10% for non-treaty investors; 5% via Hong Kong DTA (substance required). VAT: 6–13%. Social insurance underpayment is a common hidden liability in smaller Chinese businesses.
| Sector | EV/EBITDA | Key Drivers |
|---|---|---|
| {{ st.sector }} | {{ st.range }} | {{ st.drivers }} |
PRC CIT: 25% standard; 15% HNTE status (requires R&D spend, validate in FDD). Dividend WHT: 10% standard; 5% via HK DTA. MOFCOM anti-monopoly threshold: global combined turnover CNY 10B + China turnover CNY 400M, or China market share ≥25%. SAFE ODI registration required for all outbound Chinese investment. Negative List sectors restrict foreign ownership, VIE structure often used as workaround.
IVS-compliant valuations using A-share, H-share and global comparables, normalised CAS/IFRS EBITDA, and precedent transaction multiples from China deal databases. All cross-border mandates include AED/USD equivalent output.
{{ vc.body }}
A five-stage process designed for the regulatory sequencing of China M&A, with SAFE, MOFCOM and sector approvals parallel-tracked to manage timeline.
{{ p.desc }}
All fees quoted in CNY with AED equivalent. Minimum deal size CNY 10M (~AED 5M / USD 1.4M).
Financial due diligence and valuation are fixed-fee or capped-fee, agreed upfront. M&A advisory combines a retainer with a success fee at closing.
SAFE, MOFCOM and sector-specific regulatory advisory is scoped per mandate, regulatory complexity varies by sector and deal structure.
All mandates include a complimentary 30-minute discovery call to assess feasibility and provide a precise fee estimate before any engagement letter is signed.
{{ pc.desc }}
Direct answers to what clients ask most about M&A advisory for China transactions and the UAE–China corridor.
"{{ rv.text }}"
Whether selling a Chinese business to UAE/GCC buyers, or acquiring a Chinese target, we respond within 24 hours with a clear, no-obligation scope and fee.